The inaugural Big Cancer52 Conversation took place in June 2023, and brought together leaders from the charity, healthcare and pharmaceutical sectors to share best practices, exchange ideas and explore collaborations.
A follow-up event, the Big Cancer52 Conversation - Autumn Gathering was hosted six months later in November. Our Autumn Gathering provided an opportunity to review our shared progress, welcome newcomers to the conversation and explore future priorities, with the ultimate aim of improving outcomes for people with rare and less common cancers.
A panel of representatives from key stakeholder organisations opened the Big Cancer52 Conversation, highlighting main developments since the summer’s launch event. They were:
Director of Policy and Strategy for the NHS Cancer Programme, NHS England
Strategic Partnership Policy Director,
Association of the British Pharmaceutical Industry (ABPI)
Haematology Registrar at UCLH and Trustee, Cancer52
Critical to the day were the round table group sessions focused on progressing key themes identified at our June event, each tackling a key challenge faced by people affected by rare and less common cancers.
The themes are:
-
Health inequalities
-
Charities and industry working better together
-
Proxy measures for staging of blood and brain cancers
-
Better patient access to clinical trials
-
Emerging themes
If you have any questions about the Big Cancer52 Conversation, please contact cancer52events@Cancer52.org.uk.